Educational updates from the GU Oncology Symposium ? THE ...

Posted on February 3, 2012 by Sitemaster

One of the most useful elements introduced this year at the Genitourinary Cancer Symposium still ongoing in San Francisco is the summary papers from the educational reviews presented at the meeting.

In the content that follows, we have provided direct links to all of the significant summary papers dealing with key issues in the management of prostate cancer. These items can be downloaded or read on line for free and may offer useful resources for prostate cancer support group leaders and other prostate cancer educators.

• Krauss, in a paper entitled ?Role of dose escalation and supplemental androgen deprivation,? offers an overview of the appropriate use of neoadjuvant and adjuvant androgen deprivation therapy (ADT) in combination with radiation therapy in the first-line treatment of men with intermediate- and high-risk prostate cancer. This is a topic of significant importance at a time when the greater accuracy and higher doses of radiation therapy possible today may make the value of supplemental ADT more valuable in some patients and significantly less valuable (because of the risk of over-treatment)? in others.

• Lee (?Hypofractionation for prostate cancer: is less better??) discusses the rapidly evolving topic of whether fewer and higher doses of radiation may be better (or worse) for patient outcomes than older, standard forms of radiation dosing with low doses over a period of weeks. This is a key topic in the evolving use of systems like CyberKnife radiation and hypofractionated use of intensity-modulated radiation therapy (IMRT) systems.

• MacVicar (?Approved agents and related trials?) has given us a summary overview of the currently available agents in the treatment of advanced forms of prostate cancer and data from the trials of some of the newer agents that we can expect to be hearing more about in the near future.

• Sadly, Kantoff?s written summary of his presentation on sequencing of new agents in the management of castration-resistant prostate cancer is not particularly helpful. (We have to assume that his formal presentation was more informative.)

• Hall and Keller (?The bone microenvironment: does it matter??) have summarized current issues about the relationship between prostate cancer and its metastasis to bone and factors that may influence the onset and progression of bone metastasis.

• Finally, there were three other written presentations dealing with specific and detailed scientific aspects of the potential for development of new strategies to manage the later stages of prostate cancer and its management by

These last three articles will probably be heavy going f0r those without some extensive scientific background.

Like this:

Be the first to like this post.

Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment

Source: http://prostatecancerinfolink.net/2012/02/03/educational-updates-from-the-gu-oncology-symposium/

much ado about nothing sean hayes caroline manzo caroline manzo the haunting in connecticut ashram ashram